The influence of ethnicity on warfarin dosage requirement.
about
Pharmacogenetics in the management of coumarin anticoagulant therapy: the way forward or an expensive diversion?Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarinIncreased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics.Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study.Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population.The future prospects of pharmacogenetics in oral anticoagulation therapy.Evaluation of a required senior research project in a doctor of pharmacy curriculum.Influence of ethnic origin and sex on the pharmacokinetics of clazosentan.Relationship between the Occurrence of Thromboembolism and INR Measurement Interval in Low Intensity Anticoagulation after Aortic Mechanical Valve ReplacementUse of oral anticoagulants in African-American and Caucasian patients with atrial fibrillation: is there a treatment disparity?Effects of VKORC1 Genetic Polymorphisms on Warfarin Maintenance Dose Requirement in a Chinese Han Population.Cardiovascular pharmacogenomics: the future of cardiovascular therapeutics?Pharmacogenetics of chronic cardiovascular drugs: applications and implications.Effect of patient-specific factors on weekly warfarin doseRegulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement.VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-AmericansUse of genetic and nongenetic factors in warfarin dosing algorithms.Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics.Atrial Fibrillation and Race - A Contemporary Review.Ethnic differences in cardiovascular drug response: potential contribution of pharmacogeneticsInfluence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.Patient factors that influence warfarin dose response.New oral anticoagulants in practice: pharmacological and practical considerations.Review of race/ethnicity in non vitamin K antagonist oral anticoagulants clinical trials.Warfarin Pharmacogenomics in Diverse Populations.Prediction of biogeographical ancestry from genotype: a comparison of classifiers.Drug Treatment of Venous Thromboembolism in the Elderly.Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review.Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements.Single- and multiple-dose pharmacokinetics, safety and tolerability of zibotentan (ZD4054) in Chinese men with advanced solid tumors.Genetic polymorphisms are associated with variations in warfarin maintenance dose in Han Chinese patients with venous thromboembolism.Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations.The need for multicentre cardiovascular clinical trials in Asia.Vitamin K epoxide reductase complex 1 (VKORC1) haplotypes in healthy Hungarian and Roma population samples.VKORC1 and CYP2C9 allelic variants influence acenocoumarol dose requirements in Greek patients.Establishing an oral anticoagulant monitoring service in a multiethnic developing country.Shifting paradigms in the pharmacogenetics of warfarin.Accuracy of the pharmacogenetic dosing table in the warfarin label in predicting initial therapeutic warfarin doses in a large, racially diverse cohort.The VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populations.Pharmacokinetics and tolerability of almorexant in Japanese and Caucasian healthy male subjects.
P2860
Q24814457-3E899F48-D25B-4681-880D-542F63B2563FQ28276514-A5CAC230-A377-4B63-863A-36814AD2CFF3Q33613526-0A7860F8-331B-4B5A-95EE-6786D5D45194Q33770184-0F768D0C-C12E-4D9E-8DDF-C5DDE1487653Q34096562-186EC6B5-47A5-4A32-8BA1-3FA2E23B31BAQ34530230-CF532F9D-67B2-4721-B133-843469EEC827Q34628256-36833941-706D-4000-9727-A65B59D26A16Q34655124-DCEB3A01-3F60-4F5D-842D-71B0ABF2F970Q35644607-B865B0BD-DB2C-40E9-8113-5210A93EF9D3Q35654365-BA47E8F3-73A7-47FE-9BAF-B4B063077F4AQ36314728-EEB6DF29-F5C1-494A-8FE6-12C21AD8778BQ36487290-359B48CC-56B5-43DF-B7AB-2F16DD4E9489Q36543128-8074FFFB-46B8-46EC-B0F3-82E4B8C19B5CQ36661285-86224617-87AF-47DD-8F84-24EAFFE01C9AQ36835168-5476A837-8037-4138-B2E5-9BA978CB5180Q36982736-57393066-9DC9-421A-B1D2-694559DCB4E3Q37074097-1F2CA1B8-53B2-45F3-A07B-8C2EEC0D911BQ37264555-F3277327-103A-4578-854A-6062F9F4805AQ37274009-4AA0E897-4D3C-4D77-B3E7-8F4129C380FAQ37276490-E0D78215-1F1D-4F65-82E9-4CE0F92A7F22Q37376879-E31BA8CE-3BFA-4B69-B040-9F365015888DQ37867275-CBEF62B0-DC4C-4068-94EA-0D030197FADFQ38180988-D3476943-265F-44AE-BC4B-074EF2E638B7Q38264260-146CE7E4-82C1-4340-9C08-1F3933C5ED97Q38696567-F7A3EE27-BAAF-4D6E-B7AF-76F4D29428A5Q38725359-455A9E69-6CFF-4682-80EF-96963C62C5F5Q38851927-5845B4BF-7336-4261-B8C5-DFFA9D3AB123Q38958252-FFFFFEEF-581E-4F4B-9E71-2C047DAA1328Q39862947-8C7C702B-A31E-4982-B36A-5C21B351FB17Q40285992-D98AC9E3-63F0-4285-BBB6-7908B06E2DEBQ42722363-439D4DF7-58A2-4EA8-8968-293FC66834E6Q42791847-4887A322-1700-4CEB-8CF1-BD08B30DFC0AQ43609145-DD12C7C5-89FF-4326-A309-9B2F9F39F23CQ45749835-F9531D39-10FB-4F63-9CD8-6C43F66037FBQ46238853-E82150F6-14AF-4458-B621-C61F1E075508Q46265412-520CF31E-78BE-473D-A3F0-A721680B1F23Q46316268-56447F46-D213-42EC-B544-6493A733C2E3Q46466680-D0209658-0D97-4576-8B73-B3E31A36C02BQ46573199-93AA8A75-D45F-4619-AF50-F7336257618EQ46862790-0E063140-9804-47F8-B355-C42EC3D89FE7
P2860
The influence of ethnicity on warfarin dosage requirement.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
The influence of ethnicity on warfarin dosage requirement.
@en
The influence of ethnicity on warfarin dosage requirement.
@nl
type
label
The influence of ethnicity on warfarin dosage requirement.
@en
The influence of ethnicity on warfarin dosage requirement.
@nl
prefLabel
The influence of ethnicity on warfarin dosage requirement.
@en
The influence of ethnicity on warfarin dosage requirement.
@nl
P2093
P2860
P356
P1476
The influence of ethnicity on warfarin dosage requirement.
@en
P2093
Julie Hambleton
Mai-Trang N Dang
Steven R Kayser
P2860
P304
P356
10.1345/APH.1E566
P407
P577
2005-04-26T00:00:00Z